Skip to main content
logo
Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
10.24
+0.96 (10.34%)
Aug 14, 2026, 3:45 PM EDT - Market open

Sagimet Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---2--
Revenue Growth
------
Gross Profit
---2--
Operating Income
-52.63-56.89-54.45-30.74-31.06-23.72
Net Income
-47.08-51.04-45.57-27.88-30.5-24.44
Earnings Per Share
-1.25-1.58-1.45-2.66-165.20-199.40
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
257.56113.12158.6694.932.3556.73
Total Debt
1.940.080.080.070.210.35
Net Cash (Debt)
255.62113.05158.5894.8332.1356.38
Net Cash Growth
88.91%-28.71%67.22%195.11%-43.01%-17.68%
Net Cash Per Share
6.783.495.069.07174.06459.97

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-41.72-45.65-42.44-23.77-24.49-21.71
Free Cash Flow
-41.72-45.65-42.44-23.77-24.49-21.71
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
---100.00%--
Operating Margin
----1537.00%--
Pretax Margin
----1393.80%--
Profit Margin
----1393.80%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---62.05--